Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

80 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

NCT00190801

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-si, South Korea
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, South Korea
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, South Korea
View Trial Details
Active, Not Recruiting

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

NCT05489237

Conditions
Digestive System Disease, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT04084249

Conditions
Colo-rectal Cancer, Colonic Cancer, Colonic Diseases, +19 more
Locations
  • Herlev Hospital Herlev, Capital Region of Denmark, Denmark
  • Gødstrup Hospital Herning, Central Jutland, Denmark
  • Regional Hospital Horsens Horsens, Central Jutland, Denmark
  • Regional Hospital Randers Randers, Central Jutland, Denmark
View Trial Details
Active, Not Recruiting

Avatrombopag vs. Placebo for CIT in GI Malignancies

NCT05772546

Conditions
Chemotherapy-Induced Thrombocytopenia, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Oregon Health and Science University Hospital Portland, Oregon, United States
  • University of Washington Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

NCT04592913

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophagogastric Junction, +4 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sylmar, California, United States
View all 156 locations
View Trial Details
Active, Not Recruiting

CRC Detection Reliable Assessment With Blood

NCT05551052

Conditions
Adenoma, Adenomas Colon, Colon Cancer, +29 more
Locations
  • Gastro SB Chula Vista, California, United States
  • SDG Clinical Research San Diego, California, United States
  • Medical Associates Research Group San Diego, California, United States
View Trial Details

Related conditions